Life Sciences Growth: Deloitte says Denver’s next healthcare/biotech push through 2030 will be driven by AI drug discovery, personalized medicine, and tighter tech-health collaboration, building on the region’s 720+ life sciences firms and deep talent base. Crypto & Tokens: AlphaPepe presale topped $2.61M with 11,500+ holders as Ethereum price targets ($10,000) stay in focus; meanwhile Solana’s Sunrise adds ARB, reigniting debate over trading fees and execution quality. Markets & Rates: India’s growth debate heats up as World Bank’s Neelkanth Mishra argues high-frequency indicators show momentum despite skepticism over 7.8% GDP; in the UK, Chancellor John Healey unveils a £150m northern growth fund while bond-market stress raises the odds of tax rises. Corporate/Tech: Nvidia’s year-ahead forecast points to a path to $3T+ scale for AI leaders; Samsung Biologics is moving into peptide CDMO via a 3T won rights offering and PolyPeptide acquisition. Finance Infrastructure: Equiniti eyes tokenised assets in India as regulators signal openness; MoneySimpler adds real-time AI analysis to automated trading. Energy & Power Costs: A draft Northwest power plan calls for major new capacity and storage by 2032, with potential downstream rate impacts tied to data-center demand. SME & Trade: Sri Lanka’s FCCISL and the government map a nationwide push to incubate 1,000–5,000 scalable SMEs, while Zimbabwe shifts tourism strategy toward high-spending visitors (Australia highlighted).